While research into CBD is by no means common place yet, two studies coming out of the University College London have sparked the interest of the global scientific community. Although the research was done on rather small sample sizes, we must admit, the results have been incredibly promising.

The first study was published in 2013 in the Addictive Behaviors journal. The research itself was a randomized, double-blind placebo-controlled study conducted on two groups of 12 smokers. Participants in both of the groups received inhalers with instructions to use them when they felt the need to smoke during the course of a week. Even in such a short timespan, the results were shocking.

The group that was using a CBD inhaler as opposed to a placebo had reduced their nicotine intake by about 40 percent by the end of the week. Furthermore, the researchers’ follow-up meetings with these participants proved that the treatment had actually had long-term effects. Even taking into account the small sample size and the short treatment period, we can’t deny that there’s something there.

And, apparently, more researchers agreed. Another study on using CBD to quit smoking came out in May 2018. Like the previous study, this one was a randomized, double-blind crossover analysis. So although the sample size was slightly larger, at 30 participants, the premise was the same: two groups, one that was orally getting 800 mg of CBD, the other a placebo.

After the administration of the drug, the researchers tested the patients for signs of nicotine withdrawal while showing them photos that were meant to stimulate their desire for nicotine. At the end of the day, these scientists discovered that CBD significantly reversed the effects of tobacco withdrawal. Additionally, it also lessened the desire to smoke despite the”pleasantness of cigarette cues.”